Azepino-indazoles as calcitonin gene-related peptide (CGRP) receptor antagonists.


Journal

Bioorganic & medicinal chemistry letters
ISSN: 1464-3405
Titre abrégé: Bioorg Med Chem Lett
Pays: England
ID NLM: 9107377

Informations de publication

Date de publication:
01 01 2021
Historique:
received: 08 07 2020
revised: 09 10 2020
accepted: 14 10 2020
pubmed: 24 10 2020
medline: 23 7 2021
entrez: 23 10 2020
Statut: ppublish

Résumé

Calcitonin gene-related peptide (CGRP) receptor antagonists have been shown clinically to be effective treatments for migraine. Zavegepant (BHV-3500, BMS-742413) is a high affinity antagonist of the CGRP receptor (hCGRP K

Identifiants

pubmed: 33096162
pii: S0960-894X(20)30735-6
doi: 10.1016/j.bmcl.2020.127624
pii:
doi:

Substances chimiques

Azepines 0
Calcitonin Gene-Related Peptide Receptor Antagonists 0
Indazoles 0
Receptors, Calcitonin Gene-Related Peptide 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

127624

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Stephen E Mercer (SE)

Bristol-Myers Squibb, Wallingford, CT 06492, United States; Bristol Myers Squibb, Cambridge, MA 02142, United States. Electronic address: stephen.mercer@bms.com.

Prasad V Chaturvedula (PV)

Bristol-Myers Squibb, Wallingford, CT 06492, United States; Spectrum Pharmaceuticals, Irvine, CA 92618, United States.

Charles M Conway (CM)

Bristol-Myers Squibb, Wallingford, CT 06492, United States; Biohaven Pharmaceuticals Inc., New Haven, CT 06510, United States.

Deborah A Cook (DA)

Bristol-Myers Squibb, Wallingford, CT 06492, United States; Medtronic, North Haven, CT 06473, United States.

Carl D Davis (CD)

Bristol-Myers Squibb, Wallingford, CT 06492, United States; Amgen, Inc. Thousand Oaks, CA 91320, United States.

Sokhom S Pin (SS)

Bristol-Myers Squibb, Wallingford, CT 06492, United States; Cerevel Therapeutics Cambridge, MA 02141, United States.

Robert Macci (R)

Bristol-Myers Squibb, Wallingford, CT 06492, United States; Thermo Fisher Scientific, Branford, CT 06405, United States.

Richard Schartman (R)

Bristol-Myers Squibb, Wallingford, CT 06492, United States; Preformulation Solutions, LLC. North Ridgeville, OH 44039, United States.

Laura J Signor (LJ)

Bristol-Myers Squibb, Wallingford, CT 06492, United States.

Kimberly A Widmann (KA)

Bristol-Myers Squibb, Wallingford, CT 06492, United States.

Valerie J Whiterock (VJ)

Bristol-Myers Squibb, Wallingford, CT 06492, United States.

Ping Chen (P)

Bristol-Myers Squibb, Wallingford, CT 06492, United States; Bristol Myers Squibb, Lawrenceville, NJ 08543, United States.

Cen Xu (C)

Bristol-Myers Squibb, Wallingford, CT 06492, United States; Amgen, Inc. Thousand Oaks, CA 91320, United States.

John J Herbst (JJ)

Bristol-Myers Squibb, Wallingford, CT 06492, United States.

Walter A Kostich (WA)

Bristol-Myers Squibb, Wallingford, CT 06492, United States; National Multiple Sclerosis Society, New York, NY 10017, United States.

George Thalody (G)

Bristol-Myers Squibb, Wallingford, CT 06492, United States; Preformulation Solutions, LLC. North Ridgeville, OH 44039, United States.

John E Macor (JE)

Bristol-Myers Squibb, Wallingford, CT 06492, United States; Sanofi, Waltham, MA 02451, United States.

Gene M Dubowchik (GM)

Bristol-Myers Squibb, Wallingford, CT 06492, United States; Biohaven Pharmaceuticals Inc., New Haven, CT 06510, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH